Investing.com -- Shares in Thermo Fisher Scientific climbed in premarket trading Thursday after the medical equipment maker reported better-than-expected fourth-quarter results. "Thanks to our exceptional team, we delivered a strong finish to 2025, reflecting outstanding execution and the continued strength of our proven growth strategy,” said Marc Casper, chairman, president and CEO of Thermo Fisher Scientific. Our growth strategy is resonating with customers, positioning us for continued share gain, and our PPI Business System provides a strong foundation to continue our excellent operational performance." The company said it will outline its financial outlook for 2026 during its earnings conference call scheduled for 8:30 am ET. Related articlesThermo Fisher beats fourth-quarter expectations, shares climbNvidia's new Alpamayo project: What it means for Tesla?